ArticleBiomedicines2023

A Combination of an Angiotensin II Receptor and a Neprilysin Inhibitor Attenuates Liver Fibrosis by Preventing Hepatic Stellate Cell Activation.

Junya Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.